A Clinical Study To Evaluate The Shodhan Effect Of Gandirikadi Tailam Application In The Management Of Dushta Vrana(Infected Wound)

A Randomized Controlled Clinical Trial To Evaluate The Shodhan Effect Of Gandirikadi Tailam Application In The Management Of Dushta Vrana. - Nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/09/074365

Enrollment

Registered

2024-09-25

Start date

Unknown

Completion date

Unknown

Last updated

2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L089- Local infection of the skin and subcutaneous tissue, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1)Patient having complaints of infected chronic wound,Pus discharge through wound ,itching,Pain,Foul smell,Slough,Redness,Swelling 2)wound size up to 10 cm 3)Diabetic patient only those who are on treatment and maintaining their BSL 3)Patient who are ready to give written consent only will be selected

Exclusion criteria

Exclusion criteria: 1)Patient having Malignant ulcer,Tubercular ulcer,Gangrenous ulcer and Osteomylitis will be excluded 2)Patient who are not ready to give written consent 3)Uncontrolled diabetic patient 4) AIDS and HIV positive patients

Design outcomes

Primary

Measure	Time frame
To study the shodhan effect of Gandirikadi tailam application in the management of Dushtavrana . (Primary outcome will be assessed on the basis of certain objective and subjective parameters such as pain discharge tenderness floor and granulation tissue, malodour, size of wound results will be drawn with scoring system)Timepoint: 12 days study with baseline screening on 0th day. Follow-up on 4th,8th,12th day	—

Measure

Time frame

To study the shodhan effect of Gandirikadi tailam application in the management of Dushtavrana . (Primary outcome will be assessed on the basis of certain objective and subjective parameters such as pain discharge tenderness floor and granulation tissue, malodour, size of wound results will be drawn with scoring system)Timepoint: 12 days study with baseline screening on 0th day. Follow-up on 4th,8th,12th day

—

Secondary

Measure	Time frame
1)To study etiopathogenesis of Dushta vrana . 2)To study the literature of Gandirikadi tailam. data related all the drugs involved will be collected from different books & available ayurvedic literature to understand the action of drug & the disease etiopathogenesisTimepoint: 12 days study with Follow-up- on 4th,8th,12th day (overall study duration 18 month)	—

Countries

India

Contacts

Public ContactDr Payal Gajanan Gaddamwar

Mes Ayurved Mahavidyalaya

dryogeshborase@gmail.com8329008455

Outcome results